The CTO Center

Filter Your Results

 

News

 

PROGRESS-CTO Registry Studies CTO PCI in Patients With and Without Previous CABG

March 26, 2019 -- Data from the PROGRESS-CTO international registry -- which examined procedural outcomes of chronic total occlusion percutaneous coronary intervention (CTO PC…

FDA Approval Expands Indication for Medtronic's Resolute DES to Treat De Novo CTO

February 26, 2019 -- Medtronic announced FDA approval of an expanded indication for its Resolute drug-eluting stent (DES) platform for the treatment of patients with coronary …

iVascular Receives CE Mark Approval for the Navitian Coronary Microcatheter

February 15, 2019 -- iVascular announced that it has received European CE Mark approval for Navitian, the company’s new coronary microcatheter specifically designed for …

British Study Analyzes Outcomes of CTO-PCI Procedures Using Enabling Strategies

October 30, 2018 -- Online in Circulation: Cardiovascular Interventions, Tim Kinnaird, MD, et al published findings from an analysis of 28,050 cases from the British Cardiovas…

Study Looks at Temporal Trends of PCI for CTO in Europe

October 9, 2018 -- Findings from an investigation of temporal trends in chronic total occlusion (CTO) interventions in Europe were published online by Nikolaos V. Konstantinid…

SoundBite Commences ACTIVE Coronary CTO Pivotal Clinical Study

September 21, 2018 -- SoundBite Medical Solutions Inc. announced commencement of the ACTIVE trial, which was recently approved by Health Canada to evaluate the safety and effi…

Expanding the Possibilities of PCI

Ted E. Feldman, MD, MSCAI, FACC, FESC

May/June 2018— Now that percutaneous coronary intervention (PCI) has become an established therapeutic option in multiple patient populations, we find ourselves in a position to improve …

Chronic Total Occlusions: What Is Clear and What Is Controversial?

Megha Prasad, MD; and Jeffrey W. Moses, MD

May/June 2018—With improvements in technique and patient selection, operators can safely and successfully treat patients with chronic total occlusions, but further research is needed to better answer some areas of controversy.

 

advertisement

Top 5 Top 5 In CTO Center

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

Boston Scientific's CrossBoss Catheter Compared to Wire Escalation for Crossing CTOs

BD Completes Bard Acquisition

Chronic Total Occlusions: What Is Clear and What Is Controversial?

With improvements in technique and patient selection, operators can safely and successfully treat patients with chronic total occlusions, but further research is needed to better answer some areas of controversy.

By Megha Prasad, MD; and Jeffrey W. Moses, MD

FDA Approves CTO Indication for Asahi's Corsair and Coronary Guidewires

 

Centers

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

Other Resources

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.